Optimising primary molecular profiling in non-small cell lung cancer.

Autor: Schouten, R. D.¹ (AUTHOR) schouten.rd@outlook.com, Schouten, I.¹ (AUTHOR), Schuurbiers, M. M. F.² (AUTHOR), van der Noort, V.¹ (AUTHOR), Damhuis, R. A. M.³ (AUTHOR), van der Heijden, E. H. F. M.² (AUTHOR), Burgers, J. A.¹ (AUTHOR), Barlo, N. P.⁴ (AUTHOR), van Lindert, A. S. R.⁵ (AUTHOR), Maas, K. W.⁶ (AUTHOR), van den Brand, J. J. G.⁷ (AUTHOR), Smit, A. A. J.⁸ (AUTHOR), van Haarst, J. M. W.⁹ (AUTHOR), van der Maat, B.¹⁰ (AUTHOR), Schuuring, E.¹¹ (AUTHOR), Blaauwgeers, H.¹² (AUTHOR), Willems, S. M.^11,13 (AUTHOR), Monkhorst, K.¹⁴ (AUTHOR), van den Broek, D.¹⁵ (AUTHOR), van den Heuvel, M. M.^1,2 (AUTHOR)

Publikováno v: PLoS ONE. 7/31/2024, Vol. 19 Issue 7, p1-15. 15p.

Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study.

Autor: Kim, Tae-Hwan¹ (AUTHOR), Choi, Jin-Hyuk¹ (AUTHOR), Ahn, Mi Sun¹ (AUTHOR), Lee, Hyun Woo¹ (AUTHOR), Kang, Seok Yun¹ (AUTHOR), Choi, Yong Won¹ (AUTHOR) dreamliebe@hanmail.net, Koh, Young Wha² (AUTHOR), Sheen, Seung-Soo³ (AUTHOR)

Publikováno v: BMC Cancer. 1/12/2024, Vol. 24 Issue 1, p1-10. 10p.

Frequency of EGFR mutations in lung adenocarcinoma patients – A study from tertiary cancer center of South India.

Autor: Nayanar, Sangeetha¹ (AUTHOR), Mohan, Anju¹ (AUTHOR), Shenoy, Praveen² (AUTHOR), Saravanan, M³ (AUTHOR), Gopinath, Vipin⁴ (AUTHOR), Deepak Roshan, V⁴ (AUTHOR)

Publikováno v: Journal of Cancer Research & Therapeutics. 2023 Suppl 2, Vol. 19, p712-718. 7p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.